340 related articles for article (PubMed ID: 30378731)
1. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
[TBL] [Abstract][Full Text] [Related]
2. Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter.
Dicks A; Wu CL; Steward N; Adkar SS; Gersbach CA; Guilak F
Stem Cell Res Ther; 2020 Feb; 11(1):66. PubMed ID: 32070421
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
Dannenmann B; Nasri M; Welte K; Skokowa J
Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
[TBL] [Abstract][Full Text] [Related]
5. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
[TBL] [Abstract][Full Text] [Related]
7. Generation of a
Nouri P; Zimmer A; Brüggemann S; Friedrich R; Kühn R; Prakash N
Cells; 2022 Jan; 11(2):. PubMed ID: 35053384
[TBL] [Abstract][Full Text] [Related]
8. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
9. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
Getachew H; Chinchilla B; Fernandez-Godino R
Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
[TBL] [Abstract][Full Text] [Related]
10. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters.
Galdos FX; Darsha AK; Paige SL; Wu SM
Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377
[TBL] [Abstract][Full Text] [Related]
11. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
Ben Jehuda R; Shemer Y; Binah O
Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
[TBL] [Abstract][Full Text] [Related]
13. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
Higo S; Hikoso S; Miyagawa S; Sakata Y
Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
[TBL] [Abstract][Full Text] [Related]
14. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles.
Mianné J; Nasri A; Van CN; Bourguignon C; Fieldès M; Ahmed E; Duthoit C; Martin N; Parrinello H; Louis A; Iché A; Gayon R; Samain F; Lamouroux L; Bouillé P; Bourdin A; Assou S; De Vos J
BMC Biol; 2022 Jan; 20(1):8. PubMed ID: 34996449
[TBL] [Abstract][Full Text] [Related]
16. Streamlined, single-step non-viral CRISPR-Cas9 knockout strategy enhances gene editing efficiency in primary human chondrocyte populations.
Ponta S; Bonato A; Neidenbach P; Bruhin VF; Laurent A; Applegate LA; Zenobi-Wong M; Barreto G
Arthritis Res Ther; 2024 Mar; 26(1):66. PubMed ID: 38468277
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues.
Brunger JM; Zutshi A; Willard VP; Gersbach CA; Guilak F
Arthritis Rheumatol; 2017 May; 69(5):1111-1121. PubMed ID: 27813286
[TBL] [Abstract][Full Text] [Related]
18. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling.
Benetó N; Grinberg D; Vilageliu L; Canals I
Methods Mol Biol; 2022; 2549():409-425. PubMed ID: 33755903
[TBL] [Abstract][Full Text] [Related]
19. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells.
Brandão KO; Grandela C; Yiangou L; Mummery CL; Davis RP
Methods Mol Biol; 2022; 2454():531-557. PubMed ID: 33755904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
